US Patent 7173022 Bicyclic heterocycles as HIV integrase inhibitors
Patent 7173022 was granted and assigned to Bristol-Myers Squibb on February, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+369 characters)
Article
Patent abstract
The invention encompasses a series cyclic bicyclic heterocyclic compounds of Formula I which are inhibitors of HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07173022 Bicyclic heterocycles as HIV integrase inhibitors US Patent 7173022 Bicyclic heterocycles as HIV integrase inhibitors
Infobox
Patent Number
0717302200
Patent Number
717302200
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071730220
Date of Patent
February 6, 2007
0Patent Application Number
111387730
Date Filed
May 26, 2005
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071730220
Date of Patent
February 6, 2007
0Patent Application Number
111387730
Date Filed
May 26, 2005
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 20 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07173022 Bicyclic heterocycles as HIV integrase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07173022
Date of patent
February 6, 2007
Patent application number
11138773
Date Filed
May 26, 2005
Patent primary examiner
Find more entities like US Patent 7173022 Bicyclic heterocycles as HIV integrase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
